Integrative hypothesis for Huntington's disease: a brief review of experimental evidence

V Perez-De La Cruz1, A Santamaria

  • 1Laboratory of Excitatory Amino Acids, National Institute of Neurology and Neurosurgery Manuel Velasco Suárez, Mexico City, Mexico. absada@yahoo.com

Physiological Research
|December 23, 2006
PubMed

Insights

Huntington's disease (HD) involves neurodegeneration and cognitive decline. Research suggests interactions between gene mutations and toxic pathways contribute to neurotoxicity in HD patients.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Huntington's disease (HD) is an inherited neurodegenerative disorder.
  • Characterized by choreiform movements, psychiatric issues, and cognitive decline.
  • Pathology includes basal ganglia damage and specific neurochemical depletions.

Purpose of the Study:

  • To review current understanding of Huntington's disease mechanisms.
  • To explore the interplay of genetic and molecular factors in HD neurotoxicity.
  • To propose an integrative hypothesis for HD pathogenesis.

Main Methods:

  • Review of experimental evidence, including transgenic mouse models.
  • Analysis of molecular alterations, such as CAG trinucleotide expansion.
  • Examination of neurochemical and histopathological changes in HD brains.

Main Results:

  • Mutant huntingtin (htt) gene expression and aggregation are key molecular features.
  • Toxic metabolites from the kynurenine pathway interact with expanded CAG triplets.
  • Multiple toxic mechanisms, including excitotoxicity and oxidative stress, appear confluent and interdependent.

Conclusions:

  • HD pathogenesis involves complex interactions between genetic mutations and metabolic pathways.
  • An integrative hypothesis is proposed to explain the confluence of toxic mechanisms in HD.
  • Further research is needed to elucidate the predominant and complementary roles of these mechanisms.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...